Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-02FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approves a supplemental application to add a 2.5 mg strength of amlodipine besylate (generic) manufactured by Oxford Pharmaceuticals, ex…
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Hypertensive Urgency Treatment and Outcomes in a Northeast Thai Population
A completed clinical trial from Khon Kaen University evaluating treatment strategies and outcomes for hypertensive urgency in a Northeast Th…
-
CLINICAL_TRIALS research · 2018-03-30Clinical Trial Update: Compliance With The European Society Of Cardiology Prevention Guidelines In Patients at High Cardiovascular Disease Risk
This clinical trial update examines adherence to European Society of Cardiology prevention guidelines in patients at high cardiovascular ris…
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: Dietary Nitrate on Blood Pressure and Cardiovascular Disease Risk Factors [Phase 3]
This clinical trial update describes an ongoing Phase 3 study evaluating dietary nitrate for lowering blood pressure and altering cardiovasc…
-
CLINICAL_TRIALS research · 2018-03-27Clinical Trial Update: An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes
This completed observational study describes the effectiveness of a combination of an ACE inhibitor and a calcium channel blocker for managi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: Treatment Adherence and Blood Pressure Outcome Among Hypertensive Out-patients
This completed clinical trial update reports on treatment adherence and blood pressure outcomes in hypertensive outpatients conducted by the…
-
CLINICAL_TRIALS research · 2018-03-26Clinical Trial Update: Blood Pressure Control for Type 2 Diabetes [NA]
A clinical trial update (NCT03477786) from Taiwan's National Health Research Institutes on blood pressure control in people with Type 2 Diab…
-
FDA approval · 2018-03-23FDA Approved: METOPROLOL SUCCINATE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for METOPROLOL SUCCINATE (generic) from Zydus Pharmaceuticals (USA) Inc., authorizing its marketing as…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Primary Care CKD Registry [NA]
Sponsored by the University of California, San Francisco, the Primary Care CKD Registry trial focusing on hypertension and chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in Pakistan
Completed clinical study evaluating anemia in chronic kidney disease among high-risk hypertensive and diabetic patients in Pakistan. The stu…
-
CLINICAL_TRIALS research · 2018-03-20Clinical Trial Update: The Effect of Self-Titration and Predictors for Blood Pressure Control in Patients With Hypertension [NA]
This clinical trial update investigates self-titration strategies and predictors of achieving blood pressure control in adults with primary …
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: Impact of Weight Loss After a Bypass Surgery on Renal Hemodynamic Under Stress Conditions
A completed clinical trial evaluating how weight loss after a bypass surgery affects renal hemodynamics under stress conditions.
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Prospective Safety and Tolerability Assessment of a Cardiovascular Health Dietary Supplement [NA]
Completed clinical trial evaluating the safety and tolerability of a cardiovascular health dietary supplement in individuals with hypertensi…
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's supplemental application for amlodipine besylate, enabling the marketing of a generic version of the antihypertensive/an…
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the Supplemental Application for Aurobindo Pharma Limited to market amlodipine besylate as a generic formulation.
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amlodipine besylate filed by Zydus Pharmaceuticals USA Inc. The action confirms approval of …
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies [NA]
A completed study examining how antihypertensive medications influence mineral status in both experimental and clinical settings.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Non-invasive Haemodynamic Assessment in Hypertension [NA]
The trial completed a study evaluating non-invasive haemodynamic assessment in hypertension.
-
CLINICAL_TRIALS research · 2018-03-13Clinical Trial Update: Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women [NA]
A clinical trial update investigating the effect of fully blocking the Type 1 angiotensin receptor on target organ damage in postmenopausal …
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers [Phase 1]
Phase 1 study evaluating potential drug-drug interaction when co-administering Telmisartan/Amlodipine with Atorvastatin in healthy adult vol…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Vitamin D Deficiency in Patients With Hypertension [Phase 4]
A Phase 4 trial evaluating Vitamin D deficiency in patients with hypertension (NCT00974922) was terminated. Results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions [Phase 1]
This is a completed Phase 1 bioavailability study of candesartan cilexetil 16 mg tablet under fasting conditions. The sponsor is GlaxoSmithK…
-
CLINICAL_TRIALS research · 2018-03-08Clinical Trial Update: Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa
A completed clinical trial update examining the prevalence of chronic kidney disease in Sub-Saharan Africa and its risk factors. The study a…
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: HIRREM for Pre-Hypertension [NA]
Clinical trial investigating HIRREM for prehypertension has been withdrawn (status: Withdrawn). No results are reported.
-
CLINICAL_TRIALS research · 2018-03-05Clinical Trial Update: The Potential Role of Testosterone on Target Organ Damage in Postmenopausal Hypertensive Women
The document discusses a clinical trial exploring whether testosterone influences target organ damage in postmenopausal women with hypertens…